Literature DB >> 6299090

Impaired intestinal absorption of vitamin D3 in azotemic rats.

N D Vaziri, D Hollander, E K Hung, M Vo, L Dadufalza.   

Abstract

Changes in vitamin D metabolism and their effect on calcium and bone metabolism in uremia have been extensively studied. However, the possible effect of uremia on intestinal absorption of vitamin D has not been investigated. We determined the rate of intestinal absorption of vitamin D3 in uremic and normal rats using a well-defined in vivo perfusion technique under identical experimental conditions. The rate of jejunal absorption of vitamin D3 in uremic animals (5.09 +/- 1.87 pmol/100 cm/h) was significantly less (p less than 0.001) than that found in the control animals (11.5 +/- 1.6 pmol/100 cm/h). While the underlying mechanism(s) of the observed reduction in vitamin D absorption in uremia is not known, its recognition adds another dimension to the previously recognized abnormalities of vitamin D metabolism in uremia.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6299090     DOI: 10.1093/ajcn/37.3.403

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  7 in total

1.  Vitamin D and chronic kidney disease-mineral bone disease (CKD-MBD).

Authors:  Sagar U Nigwekar; Hector Tamez; Ravi I Thadhani
Journal:  Bonekey Rep       Date:  2014-02-05

2.  Feeling gutted in chronic kidney disease (CKD): Gastrointestinal disorders and therapies to improve gastrointestinal health in individuals CKD, including those undergoing dialysis.

Authors:  Annabel Biruete; Andrea Shin; Brandon M Kistler; Sharon M Moe
Journal:  Semin Dial       Date:  2021-10-27       Impact factor: 2.886

3.  Influence of Secondary Hyperparathyroidism Induced by Low Dietary Calcium, Vitamin D Deficiency, and Renal Failure on Circulating Rat PTH Molecular Forms.

Authors:  Pierre D'Amour; Louise Rousseau; Stephen Hornyak; Zan Yang; Tom Cantor
Journal:  Int J Endocrinol       Date:  2011-06-22       Impact factor: 3.257

Review 4.  Vitamin D prohormone in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease.

Authors:  Claudia Friedl; Emanuel Zitt
Journal:  Int J Nephrol Renovasc Dis       Date:  2017-05-11

Review 5.  Vitamin D Deficiency in Chronic Kidney Disease: Recent Evidence and Controversies.

Authors:  Pedro Henrique Franca Gois; Martin Wolley; Dwarakanathan Ranganathan; Antonio Carlos Seguro
Journal:  Int J Environ Res Public Health       Date:  2018-08-17       Impact factor: 3.390

6.  Effect of additive calcium administration on FGF23 levels in patients with mild chronic kidney disease treated with calcitriol: a randomized, open-labeled clinical trial.

Authors:  Nayoung Han; Su Hyun Hong; Yon Su Kim; Dong Ki Kim; In-Wha Kim; Eunhee Ji; Jung Mi Oh
Journal:  Ther Clin Risk Manag       Date:  2017-08-14       Impact factor: 2.423

Review 7.  Bone Fragility in Chronic Kidney Disease Stage 3 to 5: The Use of Vitamin D Supplementation.

Authors:  Pablo Antonio Ureña Torres; Jean Claude Souberbielle; Martine Cohen Solal
Journal:  Metabolites       Date:  2022-03-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.